Matt van de Rijn
Publication Details
-
Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.
Gynecol Oncol. 2005; (3): 684-94
The molecular pathogenesis of ovarian serous tumors of low malignant potential (S-LMP) is not well understood, although the collective data suggest that they arise through molecular mechanisms distinct from those leading to conventional serous carcinomas (S-Ca). To further examine the molecular differences between these two diseases, we studied the gene expression pattern of ovarian S-LMP and S-Ca using high-density spotted cDNA and tissue microarrays.
Help
Trial Administration